scispace - formally typeset
Journal ArticleDOI

Human gut microbiota/microbiome in health and diseases: a review

Eman Zakaria Gomaa
- 02 Nov 2020 - 
- Vol. 113, Iss: 12, pp 2019-2040
TLDR
The role of gut microbiota in maintaining host health is clarified and how nutritional and environmental factors affect the gut microbial structure and function is investigated.
Abstract
The human gut microbiota has received considerable interest in the recent years and our knowledge of the inhabitant species and their potential applications is increased particularly after the development of metagenomic studies. Gut microbiota is highly diverse and harboring trillions of microorganisms in human digestive system. The shaping and multiplication of gut microbiome starts at birth, while the modification of their composition depends mainly on various genetic, nutritional and environmental factors. The modification in the composition and function of the gut microbiota can change intestinal permeability, digestion and metabolism as well as immune responses. The pro inflammatory state caused by alternation of gut microbiota balance lead to the onset of many diseases ranging from gastrointestinal and metabolic conditions to immunological and neuropsychiatric diseases. In this context, the present review clarifies the role of gut microbiota in maintaining host health and investigates how nutritional and environmental factors affect the gut microbial structure and function. In addition, many therapeutic strategies of gut microbiota aimed at modulating and restoring of the intestinal ecosystem balance have been surveyed.

read more

Citations
More filters
Journal Article

Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome

TL;DR: Jakobsson et al. as discussed by the authors showed that short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome, and the longterm effects of antibiotic treatment have been studied.
Journal ArticleDOI

Short chain fatty acids: Microbial metabolites for gut-brain axis signalling

TL;DR: The role of the intestinal microbiota as a regulator of gut-brain axis signalling has risen to prominence in recent years as mentioned in this paper , and many studies have focused on the entry of SCFAs into systemic circulation from the gut lumen, their migration to cerebral circulation and across the blood brain barrier.
Journal ArticleDOI

Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis.

TL;DR: In this article, the authors determined the efficacy and mechanism of action of Kae as an anti-UC agent in dextran sulfate sodium (DSS)-induced colitis mice and determined that Kae pretreatment decreased the levels of IL-1β, IL-6, and TNF-α and downregulated transcription of an array of inflammatory signaling molecules, while it increased IL-10 mRNA expression.
Journal ArticleDOI

The ecological impact of a bacterial weapon: microbial interactions and the Type VI secretion system.

TL;DR: The Type VI secretion system (T6SS) is a bacterial protein secretion system that uses a bacteriophage-like machinery to secrete a diverse array of effectors, usually translocating them directly into neighbouring cells as discussed by the authors.
Journal ArticleDOI

Oyster polysaccharides ameliorate intestinal mucositis and improve metabolism in 5-fluorouracil-treated S180 tumour-bearing mice

TL;DR: In this article, oyster polysaccharide (CHP) was used to protect the intestinal barrier and improve nutritional metabolism in 5-FU-treated S180 tumour-bearing mice after treatment with CHP.
References
More filters
Journal ArticleDOI

Diet rapidly and reproducibly alters the human gut microbiome

TL;DR: Increases in the abundance and activity of Bilophila wadsworthia on the animal-based diet support a link between dietary fat, bile acids and the outgrowth of microorganisms capable of triggering inflammatory bowel disease.
Journal ArticleDOI

Richness of human gut microbiome correlates with metabolic markers

TL;DR: The authors' classifications based on variation in the gut microbiome identify subsets of individuals in the general white adult population who may be at increased risk of progressing to adiposity-associated co-morbidities.
Journal ArticleDOI

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Bertrand Routy, +76 more
- 05 Jan 2018 - 
TL;DR: It is found that primary resistance to ICIs can be attributed to abnormal gut microbiome composition, and Antibiotics inhibited the clinical benefit of ICIs in patients with advanced cancer.
Related Papers (5)